Operating Lease, Liability in USD of Sigyn Therapeutics, Inc. from Q2 2021 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Sigyn Therapeutics, Inc. quarterly Operating Lease, Liability history and change rate from Q2 2021 to Q1 2025.
Sigyn Therapeutics, Inc. Operating Lease, Liability for the quarter ending 31 Mar 2025 was $110K, a 36.5% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Sigyn Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$110K	-$63.2K	-36.5%	31 Mar 2025	10-Q	20 May 2025
Q4 2024	$126K	-$61.1K	-32.6%	31 Dec 2024	10-K	15 Apr 2025
Q3 2024	$142K	-$59.1K	-29.3%	30 Sep 2024	10-Q	19 Nov 2024
Q2 2024	$158K	-$57K	-26.5%	30 Jun 2024	10-Q	19 Aug 2024
Q1 2024	$173K	-$55.1K	-24.2%	31 Mar 2024	10-Q	14 May 2024
Q4 2023	$187K	-$53.2K	-22.1%	31 Dec 2023	10-K	20 Feb 2024
Q3 2023	$201K	-$51.3K	-20.3%	30 Sep 2023	10-Q	14 Nov 2023
Q2 2023	$215K	-$49.5K	-18.7%	30 Jun 2023	10-Q	14 Aug 2023
Q1 2023	$228K	-$47.8K	-17.3%	31 Mar 2023	10-Q	15 May 2023
Q4 2022	$241K	-$46.1K	-16.1%	31 Dec 2022	10-K	31 Mar 2023
Q3 2022	$253K	-$38.5K	-13.2%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	$265K	-$22.6K	-7.87%	30 Jun 2022	10-Q	15 Aug 2022
Q1 2022	$276K			31 Mar 2022	10-Q	13 May 2022
Q4 2021	$287K			31 Dec 2021	10-K	21 Mar 2022
Q3 2021	$291K			30 Sep 2021	10-Q	12 Nov 2021
Q2 2021	$287K			30 Jun 2021	10-Q	16 Aug 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.